[1]
“Belinostat in relapsed/refractory peripheral T-cell lymphoma: A real-world multicenter experience”, Ann Med Res , vol. 33, no. 4, pp. 178–184, Apr. 2026, Accessed: May 11, 2026. [Online]. Available: http://www.annalsmedres.org/index.php/aomr/article/view/4910